Re: OT & Shareholder Proposal

[Guest guest]

Can you let us see J & J’s corporate response? HK From: nfpprofessionals [mailto:nfpprofessionals ] On Behalf Of KippleySent: Tuesday, February 15, 2011 5:03 PMTo: nfpprofessionals Subject: OT & Shareholder Proposal To all: I thought NFPProfessionals might be interested in this. The original attachments are published below. HLI is the shareholder making the resolution; Tom Strobhar is an investment counselor who wrote the resolution. He has managed a number of such pro-life resolutions. -- Kippley We are on the ballot, despite JNJ's best efforts. This is a victory in and of itself. This is the first shareholder resolution linking steroidal birth control pills with breast cancer. The meeting has not been scheduled yet. It is likely to be held in late April. Attached is the revised resolution and JNJ's formal response. Sincerely, Tom Strobhar November 15, 2010 Mr. M. RosenbergSecretary & One & PlazaNew Brunswick, New Jersey 08933 Dear Mr. Rosenberg: We are the owner of 300 shares of & common stock. We have owned these shares continuously for over one year and at the next annual meeting of our company will present the following resolution. Resolved: The Shareholders request & to amend its Equal Employment Opportunity Policy to explicitly include the prohibition of discrimination based on the health status of an applicant. Statement: Our current Equal Employment Opportunity Policy list a number of factors where discrimination is strictly prohibited. Some of these areas reflect federal laws while others do not. By including a prohibition against discrimination because of health status in our employment policy, we reassure applicants who may have publicly disclosed serious health related issues, their application will be given serious consideration regardless of such disclosure. This is important in the case of AIDS or breast cancer where people with these diseases have publicly disclosed their condition in order to better educate the public. In the example of breast cancer, it is especially important because & manufactures a number of oral contraceptives. A meta-analysis done by Dr. Kahlenborn was published in the respected journal, Mayo Clinic Proceedings. This article noted how 21 of 23 studies demonstrated a positive correlation between the use of oral contraceptives and increased risk for breast cancer. In addition, the International Agency for Cancer Research has classified oral contraceptives as a Type 1 carcinogen. A change in our employment policy would make clear to courageous women with breast cancer and people with other diseases they need not fear decreased employment prospects from our company should they decide to make their afflictions more public. Sincerely, Dear Tom: Regarding Human Life International's shareholder proposal submitted for inclusion in the proxy statement and form of proxy for the & 2011 Annual Meeting of Shareholders, the Company intends to exercise its right to include a statement of its views regarding the proposal in its proxy materials. Therefore, pursuant to Rule 14a-8(m) of the Securities Exchange Act of 1934, as amended, we are providing to you, as the lead filer of the proposal, the attached copy of the Company’s management’s response to this proposal. Please contact me if you have any questions regarding this matter. Regards, Doug K. ChiaAssistant General Counsel & Corporate Secretary & One & PlazaNew Brunswick, NJ 08933Tel: Fax: E-mail: dchia@...

[Guest guest]

Hanna, All I have is the short note from J & J counsel to Tom Strobhar, the last piece below. I do not have the J & J response that will be given to the stockholders. Tom assures me that J & J tried to prevent the resolution from appearing, but the SEC ruled in favor of HLI.

-- K.

RE: OT & Shareholder Proposal

Can you let us see J & J’s corporate response?

HK

From: nfpprofessionals [mailto:nfpprofessionals ] On Behalf Of KippleySent: Tuesday, February 15, 2011 5:03 PMTo: nfpprofessionals Subject: OT & Shareholder Proposal

To all: I thought NFPProfessionals might be interested in this. The original attachments are published below. HLI is the shareholder making the resolution; Tom Strobhar is an investment counselor who wrote the resolution. He has managed a number of such pro-life resolutions. -- Kippley

We are on the ballot, despite JNJ's best efforts. This is a victory in and of itself. This is the first shareholder resolution linking steroidal birth control pills with breast cancer.

The meeting has not been scheduled yet. It is likely to be held in late April. Attached is the revised resolution and JNJ's formal response.

Sincerely,

Tom Strobhar

November 15, 2010

Mr. M. Rosenberg

Secretary

&

One & Plaza

New Brunswick, New Jersey 08933

Dear Mr. Rosenberg:

We are the owner of 300 shares of & common stock. We have owned these shares continuously for over one year and at the next annual meeting of our company will present the following resolution.

Resolved: The Shareholders request & to amend its Equal Employment Opportunity Policy to explicitly include the prohibition of discrimination based on the health status of an applicant.

Statement: Our current Equal Employment Opportunity Policy list a number of factors where discrimination is strictly prohibited. Some of these areas reflect federal laws while others do not. By including a prohibition against discrimination because of health status in our employment policy, we reassure applicants who may have publicly disclosed serious health related issues, their application will be given serious consideration regardless of such disclosure.

This is important in the case of AIDS or breast cancer where people with these diseases have publicly disclosed their condition in order to better educate the public. In the example of breast cancer, it is especially important because & manufactures a number of oral contraceptives. A meta-analysis done by Dr. Kahlenborn was published in the respected journal, Mayo Clinic Proceedings. This article noted how 21 of 23 studies demonstrated a positive correlation between the use of oral contraceptives and increased risk for breast cancer. In addition, the International Agency for Cancer Research has classified oral contraceptives as a Type 1 carcinogen.

A change in our employment policy would make clear to courageous women with breast cancer and people with other diseases they need not fear decreased employment prospects from our company should they decide to make their afflictions more public.

Sincerely,

Dear Tom: Regarding Human Life International's shareholder proposal submitted for inclusion in the proxy statement and form of proxy for the & 2011 Annual Meeting of Shareholders, the Company intends to exercise its right to include a statement of its views regarding the proposal in its proxy materials. Therefore, pursuant to Rule 14a-8(m) of the Securities Exchange Act of 1934, as amended, we are providing to you, as the lead filer of the proposal, the attached copy of the Company’s management’s response to this proposal. Please contact me if you have any questions regarding this matter. Regards, Doug K. ChiaAssistant General Counsel & Corporate Secretary & One & PlazaNew Brunswick, NJ 08933Tel: Fax: E-mail: dchia@...